Abstract
AbstractDespite the crucial role of phenotypic and genetic intratumoral heterogeneity in understanding and predicting clinical outcomes for patients with cancer, computational pathology studies have yet to make substantial steps in this area. The major limiting factor has been the bulk gene–sequencing practice that results in loss of spatial information of gene status, making the study of intratumoral heterogeneity difficult. In this issue of Cancer Research, Acosta and colleagues used deep learning to study if localized gene mutation status can be predicted from localized tumor morphology for clear cell renal cell carcinoma. The algorithm was developed using curated sets of matched hematoxylin and eosin and IHC images, which represent spatially resolved morphology and genotype, respectively. This study confirms the existence of a strong link between morphology and underlying genetics on a regional level, paving the way for further investigations into intratumoral heterogeneity.See related article by Acosta et al., p. 2792
Full Text
Topics from this Paper
Genetic Intratumoral Heterogeneity
IHC Images
Intratumoral Heterogeneity
Related Article
Regional Level
+ Show 5 more
Create a personalized feed of these topics
Get StartedSimilar Papers
Cell Reports
Nov 1, 2019
Clinical Cancer Research
Jun 15, 2020
iScience
Jul 1, 2020
Frontiers in Oncology
Sep 27, 2019
Cancer Research
Feb 15, 2017
Blood
Nov 29, 2018
Cancer Research
May 1, 2015
Cancer Research
Feb 15, 2017
Cancer Research
Oct 1, 2013
Mar 31, 2023
Mar 31, 2023
Cancer Research
Aug 1, 2015
Frontiers of Medicine in China
Mar 31, 2021
PLOS Medicine
Feb 10, 2015
Cancer Research
Cancer Research
Aug 15, 2023
Cancer Research
Aug 15, 2023
Cancer Research
Aug 15, 2023
Cancer Research
Aug 15, 2023
Cancer Research
Aug 15, 2023
Cancer Research
Aug 15, 2023
Cancer Research
Aug 15, 2023
Cancer Research
Aug 15, 2023
Cancer Research
Aug 15, 2023
Cancer Research
Aug 15, 2023